Lin Cheng

4.3k total citations · 1 hit paper
48 papers, 2.0k citations indexed

About

Lin Cheng is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Lin Cheng has authored 48 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 14 papers in Epidemiology and 12 papers in Molecular Biology. Recurrent topics in Lin Cheng's work include SARS-CoV-2 and COVID-19 Research (23 papers), Immune Cell Function and Interaction (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Lin Cheng is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (23 papers), Immune Cell Function and Interaction (7 papers) and Monoclonal and Polyclonal Antibodies Research (6 papers). Lin Cheng collaborates with scholars based in China, United States and Hong Kong. Lin Cheng's co-authors include Zheng Zhang, Shuye Zhang, Yang Liu, Yanling Wen, Jing Yuan, Juanjuan Zhao, Gang Xu, Jinxiu Li, Mingfeng Liao and Ido Amit and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Nature Communications.

In The Last Decade

Lin Cheng

44 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19

2020 1.6k citations Yang Liu, Jing Yuan et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lin Cheng China	12	1.3k	597	560	492	214	48	2.0k
Arjun Rustagi United States	15	871 0.7×	625 1.0×	465 0.8×	394 0.8×	202 0.9×	21	1.7k
Xianwen Zhang China	15	1.9k 1.5×	403 0.7×	668 1.2×	196 0.4×	219 1.0×	49	2.5k
Juanjuan Zhao China	17	1.3k 1.0×	1.0k 1.7×	621 1.1×	549 1.1×	531 2.5×	32	2.7k
Waradon Sungnak United States	6	1.1k 0.9×	522 0.9×	263 0.5×	501 1.0×	262 1.2×	7	2.2k
Robert Lorenz Chua Canada	15	928 0.7×	385 0.6×	406 0.7×	215 0.4×	344 1.6×	23	1.8k
Mingfeng Liao China	13	1.4k 1.1×	734 1.2×	545 1.0×	482 1.0×	384 1.8×	21	2.1k
Neta S. Zuckerman Israel	20	1.2k 1.0×	332 0.6×	389 0.7×	176 0.4×	182 0.9×	73	2.0k
Kohei Oishi United States	10	2.2k 1.7×	815 1.4×	699 1.2×	813 1.7×	474 2.2×	14	3.0k
Vanessa Monteil Sweden	14	1.6k 1.2×	182 0.3×	515 0.9×	442 0.9×	136 0.6×	23	2.1k
Yan Guo China	27	944 0.8×	446 0.7×	735 1.3×	118 0.2×	380 1.8×	67	2.0k

Countries citing papers authored by Lin Cheng

Since Specialization

Citations

This map shows the geographic impact of Lin Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Cheng more than expected).

Fields of papers citing papers by Lin Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lin Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Cheng. The network helps show where Lin Cheng may publish in the future.

Co-authorship network of co-authors of Lin Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Lin Cheng. A scholar is included among the top collaborators of Lin Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Cheng. Lin Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yansheng, Lin Cheng, Tong Wu, et al.. (2025). A multivalent mRNA vaccine elicits robust immune responses and confers protection in a murine model of monkeypox virus infection. Nature Communications. 16(1). 7373–7373. 4 indexed citations

Zheng, Bin, Jun Qiu, Lichao Liu, et al.. (2025). Discovery of a heparan sulfate binding domain in monkeypox virus H3 as an anti-poxviral drug target combining AI and MD simulations. eLife. 13. 1 indexed citations

Zhang, Xiangmei, Xian Tang, Wenqi Huang, et al.. (2025). Differential replication, pathology, and immune response of clade IIb mpox virus in C57BL/6 and BALB/c mice. Emerging Microbes & Infections. 14(1). 2479043–2479043. 1 indexed citations

Shi, Xiaoxia, Lin Cheng, Qiulong Yan, et al.. (2024). Mycobacterium tuberculosis PE_PGRS38 Enhances Intracellular Survival of Mycobacteria by Inhibiting TLR4/NF-κB-Dependent Inflammation and Apoptosis of the Host. Biology. 13(5). 313–313. 5 indexed citations

Guo, Ruochun, Shanshan Sha, Changming Chen, et al.. (2024). A population-scale analysis of 36 gut microbiome studies reveals universal species signatures for common diseases. npj Biofilms and Microbiomes. 10(1). 96–96. 8 indexed citations

Zhao, Jie, Hong Fu, Jingjing Yu, et al.. (2023). Prospect of acromegaly therapy: molecular mechanism of clinical drugs octreotide and paltusotine. Nature Communications. 14(1). 962–962. 21 indexed citations

Zhou, Bing, Shuo Song, Huimin Guo, et al.. (2022). A fourth dose of Omicron RBD vaccine enhances broad neutralization against SARS‐CoV‐2 variants including BA.1 and BA.2 in vaccinated mice. Journal of Medical Virology. 94(8). 3992–3997. 6 indexed citations

Li, Yaning, Qing Fan, Bing Zhou, et al.. (2022). Structural and functional analysis of an inter-Spike bivalent neutralizing antibody against SARS-CoV-2 variants. iScience. 25(6). 104431–104431. 8 indexed citations

Zhang, Qi, Lin Cheng, Jiwan Ge, et al.. (2022). Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2. Frontiers in Immunology. 13. 980435–980435. 12 indexed citations

10.

Wu, Xilin, Yaxin Wang, Lin Cheng, et al.. (2022). Short-Term Instantaneous Prophylaxis and Efficient Treatment Against SARS-CoV-2 in hACE2 Mice Conferred by an Intranasal Nanobody (Nb22). Frontiers in Immunology. 13. 865401–865401. 11 indexed citations

11.

Cheng, Lin, Shuo Song, Bing Zhou, et al.. (2021). Impact of the N501Y substitution of SARS-CoV-2 Spike on neutralizing monoclonal antibodies targeting diverse epitopes. Virology Journal. 18(1). 87–87. 23 indexed citations

12.

Zu, Wenhong, Yang Liu, Junhua Li, et al.. (2021). Quasispecies of SARS-CoV-2 revealed by single nucleotide polymorphisms (SNPs) analysis. Virulence. 12(1). 1209–1226. 20 indexed citations

13.

Shan, Sisi, Chee Keng Mok, Shuyuan Zhang, et al.. (2021). A Potent and Protective Human Neutralizing Antibody Against SARS-CoV-2 Variants. Frontiers in Immunology. 12. 766821–766821. 11 indexed citations

14.

Wong, Yik Chun, Liu Wan, Xin Li, et al.. (2021). Sustained viremia suppression by SHIVSF162P3CN-recalled effector-memory CD8+ T cells after PD1-based vaccination. PLoS Pathogens. 17(6). e1009647–e1009647. 5 indexed citations

15.

Wu, Xilin, Lin Cheng, Ming Fu, et al.. (2021). A potent bispecific nanobody protects hACE2 mice against SARS-CoV-2 infection via intranasal administration. Cell Reports. 37(3). 109869–109869. 61 indexed citations

16.

Liu, Jia, Kang Li, Lin Cheng, et al.. (2020). A high-throughput drug screening strategy against coronaviruses. International Journal of Infectious Diseases. 103. 300–304. 13 indexed citations

17.

Tang, Xian, Shuye Zhang, Lin Cheng, et al.. (2020). Sustained IFN-I stimulation impairs MAIT cell responses to bacteria by inducing IL-10 during chronic HIV-1 infection. Science Advances. 6(8). eaaz0374–eaaz0374. 32 indexed citations

18.

Wu, Xilin, Jia Guo, Mengyue Niu, et al.. (2018). Tandem bispecific neutralizing antibody eliminates HIV-1 infection in humanized mice. Journal of Clinical Investigation. 128(6). 2239–2251. 38 indexed citations

19.

Tang, Xian, Jia Guo, Lin Cheng, et al.. (2017). Single N277A substitution in C2 of simian immunodeficiency virus envelope influences vaccine-elicited CD4i neutralizing and anti-V2 antibody responses. Vaccine. 35(19). 2582–2591. 1 indexed citations

20.

Huang, Tao, Jinyu Hu, Bo Wang, et al.. (2013). Tlx3 Controls Cholinergic Transmitter and Peptide Phenotypes in a Subset of Prenatal Sympathetic Neurons. Journal of Neuroscience. 33(26). 10667–10675. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact